Dry Macular Degeneration Treatment in Orange County, CA
Losing clarity in your central vision can make reading, driving, recognizing faces, and enjoying everyday activities increasingly difficult. For patients diagnosed with dry age-related macular degeneration (AMD), finding effective treatment options has historically been limited. At Beach Eye Medical Group, we are proud to offer Valeda Light Therapy, a targeted light-based retinal treatment to improve vision.
Valeda Light Therapy is a non-invasive treatment designed to support retinal function in patients with dry age-related macular degeneration (AMD). Using advanced photobiomodulation technology, the Valeda Light Delivery System delivers specific wavelengths of light to the retina to help stimulate cellular activity and support visual function. Treatment sessions are comfortable, performed in-office, and require no injections or surgery.
Valeda Light Therapy is an FDA-authorized, non-invasive treatment designed for patients with dry age-related macular degeneration (AMD). Using advanced photobiomodulation technology, The treatment delivers specific wavelengths of light to the retina to help stimulate cellular activity and support retinal function.
Dry AMD can affect the macula, the portion of the retina responsible for sharp central vision needed for reading, driving, and recognizing faces. Valeda Therapy is designed to support retinal health by helping retinal cells produce and use energy more efficiently while addressing cellular stress associated with AMD progression.
Treatment sessions are comfortable, painless, and performed in-office without injections or surgery. Many patients pursue Valeda Light Therapy as part of a proactive approach to managing dry macular degeneration and preserving visual function.
Book an Appointment
Valeda Light Therapy does not involve injections, incisions, or surgery. Treatments are performed comfortably in the office.
Unlike many traditional retinal treatments that focus on wet AMD, Valeda was developed specifically for patients with dry age-related macular degeneration.
Patients can typically resume normal activities immediately after treatment sessions.
Photobiomodulation therapy is designed to support retinal metabolism and visual function at the cellular level.
Treatment sessions are short, gentle, and well-tolerated by most patients.
The best way to determine candidacy is through a detailed retinal evaluation with our experienced eye care team. You may be a candidate if you:
You will undergo a comprehensive retinal evaluation by one of our specialists to assess the severity of your dry AMD and determine whether it is the best-suited treatment.
During treatment, you will sit comfortably at the Valeda device, where specialized light therapy will be delivered to the retina. The treatment is less than 10 minutes for both eyes and is painless and non-invasive.
The recommendation is 3 treatment sessions per week, with at least 24 hours between each session, for a period of up to 4 weeks.
The light therapy is generally well tolerated, and because the dry macular degeneration treatment is non-invasive, side effects are typically minimal. Some patients may temporarily notice:
Our experienced physicians will explain all the potential risks and how they can reduce the occurrence of these risks through treatment protocols.
Beach Eye Medical Group is committed to bringing the latest advancements in retinal and ophthalmic care to patients throughout Orange County. Our team combines advanced diagnostic technology, individualized treatment planning, and compassionate patient care to help patients protect and preserve their vision. Patients choose Beach Eye Medical Group for:
Valeda red light therapy refers to the use of specific therapeutic light wavelengths to stimulate retinal cells and support visual function in patients with dry AMD.
The cost can vary depending on the recommended treatment protocol and individual patient needs. During your consultation, our team will review pricing, treatment expectations, and any applicable insurance considerations.
No. Treatment is completely non-invasive and painless. Most patients remain comfortable throughout the procedure.
Treatment sessions are relatively short, between 5 - 10 minutes in office.
No significant downtime is typically required. Most patients can return to normal daily activities immediately following treatment.
Valeda Therapy is not considered a cure for dry age-related macular degeneration. The treatment is designed to support retinal health and visual function as part of ongoing AMD management.
